Education
About Us
Working with TipRanks
Follow Us
Roger M. Klein Insider Profile
4 Followers
Roger M. Klein, Ten Percent Owner at Charah Solutions, holds 154.00K shares in Evoke Pharma (Ticker: EVOK), holds 394.46K shares in Charah Solutions (Ticker: CHRA). Most recently, Roger M. Klein Sold ― shares of Evoke Pharma on Nov 07, 2025 for an estimated value of $95.85K.
Roger M. Klein Charah Solutions (CHRA)Ten Percent Owner
Charah Solutions (CHRA)
Ten Percent Owner
Not Ranked
Ranked #24,901 out of 104,104 Corporate Insiders
Roger M. Klein has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that Roger M. Klein holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Roger M. Klein
Roger M. Klein's Trading History
Charah Solutions
Jun 30, 2023
―
Informative Buy
77.36K
$2.43M
Evoke Pharma
Nov 07, 2025
Ten Percent Owner
Informative Sell
95.85K
$1.65M
List of latest transactions for each holding click on a transaction to see Roger M. Klein's performance on stock
You May Also Like
Roger M. Klein insider profile FAQ
What is the percentage of profitable transactions made by Roger M. Klein?
The percentage of profitable transactions made by Roger M. Klein is ―.
What is the average return per transaction made by Roger M. Klein?
The average return per transaction made by Roger M. Klein is ―.
What stocks does Roger M. Klein hold?
Roger M. Klein holds: CHRA, EVOK stocks.
What was Roger M. Klein’s latest transaction?
Roger M. Klein latest transaction was an Informative Sell of $95.85K.
What was Roger M. Klein's most profitable transaction?
Roger M. Klein’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Roger M. Klein's role in Charah Solutions?
Roger M. Klein's role in Charah Solutions is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.